Monoclonal Antibodies in Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) (MARALL)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University Hospitals Birmingham Nhs Foundation
Birmingham, United Kingdom
- University of Bristol Foundation Trust
Bristol, United Kingdom
- University Hospital of Wales
Cardiff, United Kingdom
- Beatson West of Scotland Cancer Centre
Glasgow, United Kingdom
- Leeds Teaching Hospitals Nhs Trust
Leeds, United Kingdom
- Barts and the London Nhs Trust
London, United Kingdom
- Royal Free Hampstead Nhs Trust
London, United Kingdom
- Newcastle University
Newcastle, United Kingdom
- Nottingham City Hospital
Nottingham, United Kingdom
- Plymouth Hospitals Nhs Trust
Plymouth, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2010
- Primary completion
- 31 Aug 2014
- Completion
- 31 Aug 2014
- Last update posted
- 14 Jul 2014
- Registered enrollment
- 55
- Registry id
- NCT01279707
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.